Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biostat System for Lumbar IDD
NCT01011816Phase 3Terminated
- Sponsor
- Spinal Restoration, Inc.
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fibrin sealant in internal disc disruption (IDD) (2 arms), sponsored by Spinal Restoration, Inc. Primary endpoint: Subject Composite Success at 26 weeks. Started Mar 2010; status: terminated.
02
Drugs
fibrin sealant
03
Conditions
internal disc disruption (IDD)
Beyond the preview
Go deeper on NCT01011816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011816.